Sector: Healthcare | Industry: Biotechnology & Medical Research |
Company Contact | |
Address: | 130 Eileen Stubbs Ave., Suite 19 DARTMOUTH NS B3B 2C4 |
Tel: | 1-902-4921819 |
Website: | https://imv-inc.com |
IR: | See website |
Key People | ||
Andrew Hall Chief Executive Officer, Director | Brittany Davison Acting Chief Financial Officer, Chief Accounting Officer | Jeremy R. Graff Chief Scientific Officer |
Business Overview |
IMV Inc. is a Canada-based company. The Company has no business operations. |
Financial Overview |
For the fiscal year ended 31 December 2022, Imv Inc revenues increased 75% to $329K. Net loss increased 4% to $38M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Government assistance decrease of 45% to $1.8M (income), General and administrative increase of 6% to $17M (expense), Research and development increase of 1% to $23.3M (expense). |
Employees: | 63 as of Dec 31, 2022 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $7.67M as of Dec 31, 2022 |
Annual revenue (TTM): | $0.33M as of Dec 31, 2022 |
EBITDA (TTM): | -$38.94M as of Dec 31, 2022 |
Net annual income (TTM): | -$37.99M as of Dec 31, 2022 |
Free cash flow (TTM): | -$34.47M as of Dec 31, 2022 |
Net Debt Last Fiscal Year: | $7.67M as of Dec 31, 2022 |
Shares outstanding: | 11,711,637 as of Mar 15, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |